Detalles de la búsqueda
1.
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
Ann Intern Med
; 175(9): 1250-1257, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994748
2.
A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety.
Stat Med
; 41(10): 1735-1750, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092037
3.
Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.
Int J Cancer
; 148(2): 375-384, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683691
4.
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
N Engl J Med
; 388(15): 1431-1432, 2023 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988584
5.
Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis.
Blood
; 134(3): 227-238, 2019 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31003999
6.
Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study.
Blood
; 138(5): 417-420, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876243
7.
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
JAMA
; 327(1): 80-82, 2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807248
8.
Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study.
J Infect Public Health
; 17(7): 102450, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823086
9.
Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
Neurology
; 101(21): e2094-e2102, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788935
10.
Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case-Control Study Based on the French National Health Data System.
Open Forum Infect Dis
; 10(10): ofad460, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37808897
11.
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.
Nat Commun
; 13(1): 3633, 2022 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35752614
12.
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Vaccine
; 40(3): 414-417, 2022 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34924220
13.
Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France.
Lancet Reg Health Eur
; 19: 100441, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789881
14.
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study.
BMJ Med
; 1(1): e000104, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936561
15.
Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.
Cancers (Basel)
; 11(10)2019 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31569513
16.
Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
JAMA Netw Open
; 2(1): e187147, 2019 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30657534
17.
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
JAMA Netw Open
; 5(3): e220868, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35234883
Resultados
1 -
17
de 17
1
Próxima >
>>